TJC Completes Acquisition of Delrin®
TJC L.P. (“TJC”) announced the successful close of the acquisition of Delrin®, a highly differentiated, global homopolymer business.
- TJC L.P. (“TJC”) announced the successful close of the acquisition of Delrin®, a highly differentiated, global homopolymer business.
- Today marks the launch of Delrin® as an independent company, building on a 60+ year legacy of partnering with customers to help solve their toughest technical challenges.
- Delrin’s employees and operations will continue to operate the business in the normal course, providing stability and consistency to customers and suppliers with whom the Company maintains long-standing relationships.
- After previous roles at Celanese, Avantor and BASF, Juergen’s most recent role was President of Biotherapeutics and Pharmaceuticals at ILC Dover.